Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Latent
Latent raises $80M for AI medication approval platform
By
Jessica Hagen
|
01:02 pm |
March 20, 2026
The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.
